Treatment News : Aquamid a Safe and Effective Treatment for Facial Wasting

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2009

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

April 28, 2009

Aquamid a Safe and Effective Treatment for Facial Wasting

Aquamid (polyacrylamide hydrogel) injections are a safe and long-lasting treatment for facial wasting, according to a study published in the April issue of AIDS Research and Human Retroviruses and reported by aidsmap.

Though the percentage of people who develop facial wasting, or lipoatrophy, has diminished since health care providers moved away from prescribing the antiretrovirals Zerit (stavudine) and Retrovir (zidovudine), a significant number of people still have untreated lipoatrophy. Moreover, the two fillers approved in the United States to treat the condition are temporary treatments and must usually be reapplied to maintain facial fullness.

To determine the long-term effectiveness and safety of a new, permanent filler called Aquamid, Eugenia Negredo, MD, from the Universitat Autònoma de Barcelona, and her colleagues treated 145 people with HIV and varying degrees of facial wasting. Most of the patients were male and had been infected with HIV for about 16 years. The average age was 47, and nearly two thirds had severe facial lipoatrophy. The patients received injections of Aquamid every three weeks until a desired fullness in the face was achieved. The authors did not state the average number of treatments that were given, but the average total volume of Aquamid used was 5.5 milliliters.

Negredo’s team found that Aquamid implants were relatively safe. Only one patient had a serious infection, which was treatable with oral antibiotics. Nineteen percent had small nodules that were not readily visible, and 6 percent had hardening of the facial skin. Just 9 percent of the patients required follow-up injections after reaching a desired facial fullness during the follow-up period averaging four years.

While the authors conclude that their study demonstrates the relative efficacy and safety of Aquamid, they also caution that “continued and prolonged follow-up of these patients is recommended to treat complications and detect unexpected long-term adverse reactions.”

Search: Aquamid, polyacrylamide hydrogel, facial wasting, facial filler, lipoatrophy, Eugenia Negredo


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (4 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    aqua_31206
    Macon
    Georgia


    Sloan1
    Dallas
    Texas


    pevans
    San Francisco
    California


    blaze11212
    brooklyn
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Is HIV/AIDS adequately portrayed in pop culture?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.